Therapeutic Goods (Standard for Labelling of Prescription Medicines) (TGO 115) Order 2026

In force

This text since 28 Sept 2026

law://au/li/2026/f2026l01311/pt_3Labellingrequirementsforprimarypacksintermediatepackagingandcontainers__div_2Labelsonintermediatepackaging@2026-11-13

Contents

Division 2—Labels on intermediate packaging

13 Information to be included on the label on intermediate packaging #

If the information required to be on the label on a container is obscured by intermediate packaging, the intermediate packaging must be labelled with all of the following information:

(a)the name of the medicine;

(b)the name of each active ingredient in the medicine;

(c)the quantity or proportion of each active ingredients in the medicine;

(d)the batch number, accompanied by the batch number identifier;

(e)the expiry date, accompanied by the expiry date identifier;

(f)the name of the sponsor, or a registered trade mark if it readily identifies the name of the sponsor of the medicine.

Sourced from the Federal Register of Legislation at legislation.gov.au, © Commonwealth of Australia, licensed under CC BY 4.0. Compilations may have been reformatted.

Therapeutic Goods (Standard for Labelling of Prescription Medicines) (TGO 115) Order 2026

Division 2—Labels on intermediate packaging

13 Information to be included on the label on intermediate packaging #

Defined terms · 12

Key facts

History · 1 version

Division 2—Labels on intermediate packaging

13 Information to be included on the label on intermediate packaging #

Division 2—Labels on intermediate packaging

13 Information to be included on the label on intermediate packaging#

Defined terms · 12

Key facts

History · 1 version

Division 2—Labels on intermediate packaging

13 Information to be included on the label on intermediate packaging#

13 Information to be included on the label on intermediate packaging #

13 Information to be included on the label on intermediate packaging #